Latest Regulatory Process News

Iron Bear Resources has applied for its Labrador Trough iron ore project to be designated a Project of National Significance under Canada's new Building Canada Act, aiming to fast-track approvals and financing.

MFF Capital Investments’ May update shows a modest fall in net tangible assets per share and outlines a cautious yet optimistic portfolio stance amid geopolitical tensions and technological advances.

Turnstone Resources has exercised its option to acquire the Glava 100 copper-gold permit in Sweden, broadening its critical minerals footprint to seven licences across 100km2. The move sets the stage for drilling in H2 2026, pending regulatory approvals.

Albion Resources has finalized its acquisition of the Gidgee Gold Project in Western Australia's Gum Creek Greenstone Belt and is gearing up for drilling after receiving soil sampling results.

The Therapeutic Goods Administration has broadened the range of clinicians eligible to participate in psychedelic-assisted psychotherapy, a move set to speed up recruitment and improve patient access across Emyria’s national Empax network.

Bremworth Limited reiterates confidence in its Floorscape acquisition scheme despite ongoing regulatory uncertainty, signalling readiness to explore alternatives if the New Zealand Commerce Commission declines clearance.

AdAlta has engaged specialist advisors to streamline US FDA regulatory processes for its CAR-T therapy BZDS1901, which has shown rare complete tumour clearance in advanced mesothelioma patients.

Dataworks has officially launched BetGuard, iGaming Ontario's Centralised Self-Exclusion tool, alongside a dedicated Contact Centre, marking its expansion into a second regulated jurisdiction for responsible gambling technology.

Chariot Resources has broadened its Nigerian lithium acquisition by adding a key small-scale mining licence and converting three leases to mining leases, extending the acquisition timeline and increasing regulatory costs.

Lumos Diagnostics has reached a key enrolment milestone in its BARDA-backed FebriDx paediatric trial, unlocking a US$670,000 payment and advancing its FDA submission pathway to expand use in children aged 2-12 years.

Diamond Infraco, backed by IFM Global Infrastructure Fund, has lodged a Takeovers Panel application alleging material disclosure deficiencies in Atlas Arteria's takeover bid documents, centering on governance rights tied to the Chicago Skyway asset.

Santana Minerals has corrected its timeline for settling the purchase of 3,680 hectares for its Bendigo-Ophir Project, extending the deadline to the earlier of mid-2030 or 12 months after mining consents are granted.